BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3201554)

  • 1. DR phenotype matching and transfusion in patients treated with cyclosporine.
    Cicciarelli J; Terasaki PI
    Transplant Proc; 1988 Dec; 20(6):1082-3. PubMed ID: 3201554
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of HLA matching and pretransplant blood transfusions in cyclosporine-treated recipients of cadaveric renal allografts: 2- to 3-year results.
    Lundgren G; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Gäbel H; Lindholm A; Maurer W; Möller E; Persson H
    Transplant Proc; 1987 Oct; 19(5):3614-8. PubMed ID: 3313870
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment protocols: is there a role for tissue typing in renal transplantation?
    Ferguson RM
    Transplant Proc; 1988 Dec; 20(6 Suppl 8):42-5. PubMed ID: 3059621
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy.
    Vanrenterghem Y; Roels L; Waer M; Gruwez J; Dendievel J; Michielsen P
    Transplant Proc; 1987 Feb; 19(1 Pt 1):685-6. PubMed ID: 3274841
    [No Abstract]   [Full Text] [Related]  

  • 5. Survival of cadaveric donor renal allografts in cyclosporine A-treated recipients: the influence of HLA-DR antigen matching.
    Madsen M; Fjeldborg O; Graugaard B; Posborg V; Kissmeyer-Nielsen F
    Transplant Proc; 1988 Jun; 20(3):369-71. PubMed ID: 3381251
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of HLA matching and lymphocytotoxic antibody status in heart-lung allograft recipients receiving cyclosporin and azathioprine.
    Festenstein H; Banner N; Smith J; Awad J; Burden M; Fitzgerald N; Holmes J; Khaghani A; Smith J; McCloskey D
    Transplant Proc; 1989 Feb; 21(1 Pt 1):797-8. PubMed ID: 2495632
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of HLA matching and blood transfusions in the cyclosporine era. Collaborative Transplant Study.
    Opelz G
    Transplant Proc; 1989 Feb; 21(1 Pt 1):609-12. PubMed ID: 2705239
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood transfusions and HLA matching--an either/or situation in cadaveric renal transplantation.
    Cecka JM; Cicciarelli J; Mickey MR; Terasaki PI
    Transplantation; 1988 Jan; 45(1):81-6. PubMed ID: 3276068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin, HLA matching, and transfusions in kidney transplants.
    Persijn GG; Schreuder GM; Hendriks GF; Cohen B; D'Amaro J; van Rood JJ
    Lancet; 1986 Oct; 2(8512):915-6. PubMed ID: 2876342
    [No Abstract]   [Full Text] [Related]  

  • 10. The importance of HLA-DR matching in corneal transplant recipients treated with cyclosporine A.
    von Keyserlingk H; Offermann G; Wiederholt M; Hoffmann F
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2576-8. PubMed ID: 3274567
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of DR and DR6 matching on cadaver kidney transplant survival.
    Reyman TA; Toledo-Pereyra LH
    Transplant Proc; 1987 Feb; 19(1 Pt 1):702-4. PubMed ID: 3274848
    [No Abstract]   [Full Text] [Related]  

  • 12. No effect of blood transfusions or HLA matching on renal graft success rate in recipients treated with cyclosporine-prednisolone or cyclosporine-azathioprine-prednisolone: the Scandinavian experience.
    Brynger H; Persson H; Flatmark A; Albrechtsen D; Frödin L; Tufvesson G; Gäbel H; Weibull H; Möller E; Lundgren G
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):261-3. PubMed ID: 3291253
    [No Abstract]   [Full Text] [Related]  

  • 13. Is cyclosporine a match for tissue typing centers? Role of the zero HLA-A, B, and DR mismatch effect.
    Cicciarelli J; Terasaki PI; Cecka M; Mickey MR
    Transplant Proc; 1987 Feb; 19(1 Pt 1):647-9. PubMed ID: 3274831
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of cyclosporine immunosuppression in humans.
    Kerman RH
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):143-52. PubMed ID: 3284064
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients.
    Kerman RH; Van Buren CT; Lewis RM; Kahan BD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):264-9. PubMed ID: 3291254
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of cyclosporine A on risk factors in renal transplantation.
    Disney AP
    Transplant Proc; 1987 Apr; 19(2):2829-33. PubMed ID: 3551220
    [No Abstract]   [Full Text] [Related]  

  • 17. Cadaveric renal transplantation after pulsatile perfusion, histocompatibility matching, and conversion to cyclosporine therapy.
    Milgrom M; Kyriakides GK; Esquenazi V; Olson L; Miller J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1873. PubMed ID: 3274444
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and socioeconomic benefits of serological HLA-DR matching for renal transplantation over three eras of immunosuppression regimens at a single unit.
    Taylor CJ; Welsh KI; Gray CM; Bunce M; Bayne AM; Sutton PM; Gray DW; Ting A; Morris PJ
    Clin Transpl; 1993; ():233-41. PubMed ID: 7918156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective HLA typing is helpful in cadaveric renal transplantation.
    van Rood JJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):139-43. PubMed ID: 3547809
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of HLA matching in cardiac allograft recipients in a single center.
    Raffoux C; Mayor V; Cabrol C; Busson M; Hors J; Colombani J
    Transplant Proc; 1987 Oct; 19(5):3559-60. PubMed ID: 3313858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.